BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arora U, Garg P, Agarwal S, Nischal N, Shalimar, Wig N. Complexities in the treatment of coinfection with HIV, hepatitis B, hepatitis C, and tuberculosis. Lancet Infect Dis 2021;21:e399-406. [PMID: 34023004 DOI: 10.1016/S1473-3099(20)30765-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Marino A, Zafarana G, Ceccarelli M, Cosentino F, Moscatt V, Bruno G, Bruno R, Benanti F, Cacopardo B, Celesia BM. Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV/HCV Coinfected Patients: Monocentric Italian Experience. Diagnostics (Basel) 2021;11:2336. [PMID: 34943573 DOI: 10.3390/diagnostics11122336] [Reference Citation Analysis]
2 Morojele NK, Shenoi SV, Shuper PA, Braithwaite RS, Rehm J. Alcohol Use and the Risk of Communicable Diseases. Nutrients 2021;13:3317. [PMID: 34684318 DOI: 10.3390/nu13103317] [Reference Citation Analysis]
3 Valle-Millares D, Brochado-Kith Ó, Martín-Carbonero L, Domínguez-Domínguez L, Ryan P, De Los Santos I, De la Fuente S, Castro JM, Lagarde M, Cuevas G, Mayoral-Muñoz M, Matarranz M, Díez V, Gómez-Sanz A, Martínez-Román P, Crespo-Bermejo C, Palladino C, Muñoz-Muñoz M, Jiménez-Sousa MA, Resino S, Briz V, Fernández-Rodríguez A, On Behalf Of Multidisciplinary Group Of Viral Coinfection Hiv/Hepatitis Covihep. Different HCV Exposure Drives Specific miRNA Profile in PBMCs of HIV Patients. Biomedicines 2021;9:1627. [PMID: 34829855 DOI: 10.3390/biomedicines9111627] [Reference Citation Analysis]